<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Tropical Medicine Reports2196-3045Springer International PublishingCham pmcid: 7335730207 doi: 10.1007/s40475-020-00207-0 :" exact="Metabolism" post="in Tropical Medicine (K Schlosser Montes, Section Editor) Obesity,"/>
 <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
 <result pre="Abstract Purpose of Review To better understand the impact of" exact="obesity" post="and cardiovascular diseases on influenza A infection. Recent Findings"/>
 <result pre="of Review To better understand the impact of obesity and" exact="cardiovascular" post="diseases on influenza A infection. Recent Findings This infection"/>
 <result pre="and cardiovascular diseases on influenza A infection. Recent Findings This" exact="infection" post="could have detrimental outcomes in obese patients with cardiovascular"/>
 <result pre="This infection could have detrimental outcomes in obese patients with" exact="cardiovascular" post="diseases, such as an increased risk, length of hospitalization,"/>
 <result pre="cardiovascular diseases, such as an increased risk, length of hospitalization," exact="disease" post="severity, morbidity, and mortality. Nevertheless, there also might be"/>
 <result pre="with influenza vaccination, such as a reduced mortality, hospitalization, and" exact="acute" post="coronary syndromes, in patients with coronary heart disease and/or"/>
 <result pre="reduced mortality, hospitalization, and acute coronary syndromes, in patients with" exact="coronary heart disease" post="and/or heart failure. Summary Obesity negatively impacts immune function"/>
 <result pre="mortality, hospitalization, and acute coronary syndromes, in patients with coronary" exact="heart" post="disease and/or heart failure. Summary Obesity negatively impacts immune"/>
 <result pre="hospitalization, and acute coronary syndromes, in patients with coronary heart" exact="disease" post="and/or heart failure. Summary Obesity negatively impacts immune function"/>
 <result pre="acute coronary syndromes, in patients with coronary heart disease and/or" exact="heart" post="failure. Summary Obesity negatively impacts immune function and host"/>
 <result pre="in patients with coronary heart disease and/or heart failure. Summary" exact="Obesity" post="negatively impacts immune function and host defense. Recent studies"/>
 <result pre="negatively impacts immune function and host defense. Recent studies report" exact="obesity" post="to be an independent risk factor for increased morbidity"/>
 <result pre="comprehend the mechanisms behind the reduced immunocompetence when influenza A" exact="infection" post="occurs. Future studies should focus on special consideration treatments"/>
 <result pre="treatments when the patients have not been vaccinated and have" exact="cardiovascular" post="diseases. Keywords Obesity Influenza Cardiovascular disease Cardioprotective effects of"/>
 <result pre="patients have not been vaccinated and have cardiovascular diseases. Keywords" exact="Obesity" post="Influenza Cardiovascular disease Cardioprotective effects of vaccination Influenza vaccine"/>
 <result pre="been vaccinated and have cardiovascular diseases. Keywords Obesity Influenza Cardiovascular" exact="disease" post="Cardioprotective effects of vaccination Influenza vaccine Introduction This review"/>
 <result pre="of vaccination Influenza vaccine Introduction This review focuses on how" exact="obesity" post="and cardiovascular disease impact influenza response. Retrospective studies demonstrate"/>
 <result pre="Influenza vaccine Introduction This review focuses on how obesity and" exact="cardiovascular disease" post="impact influenza response. Retrospective studies demonstrate that during the"/>
 <result pre="vaccine Introduction This review focuses on how obesity and cardiovascular" exact="disease" post="impact influenza response. Retrospective studies demonstrate that during the"/>
 <result pre="response. Retrospective studies demonstrate that during the 2009 H1N1 pandemic," exact="obesity" post="was identified as a risk factor for hospitalization, mechanical"/>
 <result pre="by 2050. Several case studies have identified possible effects of" exact="obesity" post="on viral replication in the deep lung, progression to"/>
 <result pre="Several case studies have identified possible effects of obesity on" exact="viral" post="replication in the deep lung, progression to viral pneumonia,"/>
 <result pre="obesity on viral replication in the deep lung, progression to" exact="viral pneumonia," post="and prolonged viral shedding [1]. Therefore, management of the"/>
 <result pre="in the deep lung, progression to viral pneumonia, and prolonged" exact="viral" post="shedding [1]. Therefore, management of the influenza infection in"/>
 <result pre="and prolonged viral shedding [1]. Therefore, management of the influenza" exact="infection" post="in this at-risk population has to have special consideration"/>
 <result pre="given that they may not respond optimally to vaccination [2]." exact="Obesity" post="and Its Impact on Influenza Infection Excessive fat accumulation"/>
 <result pre="optimally to vaccination [2]. Obesity and Its Impact on Influenza" exact="Infection" post="Excessive fat accumulation that results in obesity impairs health"/>
 <result pre="Impact on Influenza Infection Excessive fat accumulation that results in" exact="obesity" post="impairs health for adults [3]. Its low-grade chronic inflammatory-induced"/>
 <result pre="results in obesity impairs health for adults [3]. Its low-grade" exact="chronic" post="inflammatory-induced state negatively impacts immune function and host defense"/>
 <result pre="shown during the 2009 influenza A virus H1N1 pandemic, where" exact="obesity" post="resulted to be an independent risk factor for severe"/>
 <result pre="factor for severe disease, hospitalization, mechanical ventilation, and mortality upon" exact="infection" post="[1]. It is well known that influenza A virus"/>
 <result pre="upon infection [1]. It is well known that influenza A" exact="virus infection" post="is characterized by fever, myalgia, rhinorrhea, sore throat, and"/>
 <result pre="infection [1]. It is well known that influenza A virus" exact="infection" post="is characterized by fever, myalgia, rhinorrhea, sore throat, and"/>
 <result pre="throat, and sneezing. These symptoms peak 3â€&quot;5Â days post-infection, with" exact="viral" post="shedding peaking at days 2â€&quot;3. Usually, it is limited"/>
 <result pre="with viral shedding peaking at days 2â€&quot;3. Usually, it is" exact="limited" post="to the upper respiratory tract; however, in severe cases,"/>
 <result pre="peaking at days 2â€&quot;3. Usually, it is limited to the" exact="upper" post="respiratory tract; however, in severe cases, the lower respiratory"/>
 <result pre="at days 2â€&quot;3. Usually, it is limited to the upper" exact="respiratory" post="tract; however, in severe cases, the lower respiratory tract,"/>
 <result pre="to the upper respiratory tract; however, in severe cases, the" exact="lower" post="respiratory tract, including the lungs, can be affected and"/>
 <result pre="the upper respiratory tract; however, in severe cases, the lower" exact="respiratory" post="tract, including the lungs, can be affected and often"/>
 <result pre="progression is more common in obese patients, leading to diminish" exact="infection" post="resolution when compared with non-obese patients [1]. Obesity also"/>
 <result pre="to diminish infection resolution when compared with non-obese patients [1]." exact="Obesity" post="also plays a role in the outcome of critical"/>
 <result pre="role in the outcome of critical complications from influenza A/pdmH1N1" exact="infection" post="and is associated with longer mechanical ventilation for severe"/>
 <result pre="infection and is associated with longer mechanical ventilation for severe" exact="acute" post="respiratory distress syndrome and shock [4]. A higher body"/>
 <result pre="and is associated with longer mechanical ventilation for severe acute" exact="respiratory" post="distress syndrome and shock [4]. A higher body mass"/>
 <result pre="associated with longer mechanical ventilation for severe acute respiratory distress" exact="syndrome" post="and shock [4]. A higher body mass index (BMI)"/>
 <result pre="and shock [4]. A higher body mass index (BMI) and" exact="metabolic syndrome" post="in patients with influenza have shown an increased risk"/>
 <result pre="shock [4]. A higher body mass index (BMI) and metabolic" exact="syndrome" post="in patients with influenza have shown an increased risk"/>
 <result pre="shown an increased risk and length of hospitalization [4â€&quot;6], increased" exact="disease" post="severity, morbidity, and mortality during lower respiratory tract infections."/>
 <result pre="of hospitalization [4â€&quot;6], increased disease severity, morbidity, and mortality during" exact="lower" post="respiratory tract infections. This might be explained in part"/>
 <result pre="hospitalization [4â€&quot;6], increased disease severity, morbidity, and mortality during lower" exact="respiratory" post="tract infections. This might be explained in part by"/>
 <result pre="variety of mechanisms by which nutritional imbalances could alter within-host" exact="viral" post="evolution [8]. Studies have shown that such imbalances prolong"/>
 <result pre="(42% longer than non-obese) [9], all of which potentially increase" exact="viral" post="transmission [1]. In addition to the decreased immunocompetence mechanisms,"/>
 <result pre="immunocompetence mechanisms, other potential factors might contribute to its increased" exact="susceptibility to" post="infection in the hospital setting. Some examples, which are"/>
 <result pre="other potential factors might contribute to its increased susceptibility to" exact="infection" post="in the hospital setting. Some examples, which are underlying"/>
 <result pre="increase risk for skin problems, prolonged visits at hospitals and" exact="nosocomial infections," post="alteration in the pharmacokinetics of some drugs, and an"/>
 <result pre="alteration in the pharmacokinetics of some drugs, and an increased" exact="susceptibility to" post="post-surgery infections [2]. Thus, it is a complex problem"/>
 <result pre="pharmacokinetics of some drugs, and an increased susceptibility to post-surgery" exact="infections" post="[2]. Thus, it is a complex problem that needs"/>
 <result pre="better treatments for this increasing population. Importance of Influenza Vaccination" exact="Obesity" post="causes a chronic state of inflammation in a generalized"/>
 <result pre="this increasing population. Importance of Influenza Vaccination Obesity causes a" exact="chronic" post="state of inflammation in a generalized and constant way"/>
 <result pre="on immunity. Obese people have delayed immune responses to influenza" exact="virus infection" post="and experience slower recovery from the disease. In addition,"/>
 <result pre="immunity. Obese people have delayed immune responses to influenza virus" exact="infection" post="and experience slower recovery from the disease. In addition,"/>
 <result pre="is reduced in this population causing an alteration of the" exact="viral" post="life cycle and, coupled with an already weakened and"/>
 <result pre="a more serious condition. Poor initial and adaptive responses to" exact="infection" post="and vaccination create an impaired ability to respond appropriately"/>
 <result pre="are needed to better understand how the obese state affects" exact="infection" post="control [1]. Previous studies suggest that the severity of"/>
 <result pre="control [1]. Previous studies suggest that the severity of influenza" exact="virus infection" post="is multifactorial and may be related to lung spread"/>
 <result pre="[1]. Previous studies suggest that the severity of influenza virus" exact="infection" post="is multifactorial and may be related to lung spread"/>
 <result pre="B. A study conducted in 2013â€&quot;2015 aimed at evaluating whether" exact="obesity" post="was associated with an increased risk of influenza for"/>
 <result pre="appears that in high-risk groups, such as the obese and" exact="overweight" post="population, vaccination may not provide optimal protection, and because"/>
 <result pre="provide optimal protection, and because of the growing trend of" exact="obesity" post="worldwide, the efficacy of the vaccine should be improved"/>
 <result pre="the efficacy of the vaccine should be improved [10]. Among" exact="cardiovascular disease" post="patients, there is compelling evidence that shows lower risk"/>
 <result pre="efficacy of the vaccine should be improved [10]. Among cardiovascular" exact="disease" post="patients, there is compelling evidence that shows lower risk"/>
 <result pre="Among cardiovascular disease patients, there is compelling evidence that shows" exact="lower" post="risk of major adverse cardiovascular events, reduced hospitalization, and"/>
 <result pre="is compelling evidence that shows lower risk of major adverse" exact="cardiovascular" post="events, reduced hospitalization, and mortality [13â€&quot;15], being the greatest"/>
 <result pre="was seen among the highest-risk patients with more active coronary" exact="disease" post="[15]. The recent recommendation advocates the priority of vaccination"/>
 <result pre="in the obese population [9, 10]. Cardiovascular Risk and Influenza" exact="Infection" post="In the twentieth century during influenza epidemics, there has"/>
 <result pre="influenza epidemics, there has been an excess of mortality from" exact="cardiovascular disease" post="[16]. A recent study that included 364 hospitalizations for"/>
 <result pre="epidemics, there has been an excess of mortality from cardiovascular" exact="disease" post="[16]. A recent study that included 364 hospitalizations for"/>
 <result pre="disease [16]. A recent study that included 364 hospitalizations for" exact="acute" post="myocardial infarction demonstrated an increased risk of acute myocardial"/>
 <result pre="[16]. A recent study that included 364 hospitalizations for acute" exact="myocardial infarction" post="demonstrated an increased risk of acute myocardial infarction within"/>
 <result pre="hospitalizations for acute myocardial infarction demonstrated an increased risk of" exact="acute" post="myocardial infarction within one week after influenza virus infection"/>
 <result pre="for acute myocardial infarction demonstrated an increased risk of acute" exact="myocardial infarction" post="within one week after influenza virus infection to a"/>
 <result pre="risk of acute myocardial infarction within one week after influenza" exact="virus infection" post="to a risk that was six times higher than"/>
 <result pre="of acute myocardial infarction within one week after influenza virus" exact="infection" post="to a risk that was six times higher than"/>
 <result pre="risk during the year before or after the onset of" exact="infection" post="[17]. Cardiovascular complications associated with influenza infection include myocarditis,"/>
 <result pre="the onset of infection [17]. Cardiovascular complications associated with influenza" exact="infection" post="include myocarditis, pericardial effusion, myopericarditis, right and left ventricle"/>
 <result pre="infection [17]. Cardiovascular complications associated with influenza infection include myocarditis," exact="pericardial effusion," post="myopericarditis, right and left ventricle dysfunction, myocardial infarction, heart"/>
 <result pre="include myocarditis, pericardial effusion, myopericarditis, right and left ventricle dysfunction," exact="myocardial infarction," post="heart failure, stroke, and circulatory failure due to septic"/>
 <result pre="pericardial effusion, myopericarditis, right and left ventricle dysfunction, myocardial infarction," exact="heart" post="failure, stroke, and circulatory failure due to septic shock"/>
 <result pre="myocardial infarction, heart failure, stroke, and circulatory failure due to" exact="septic shock" post="[13, 18â€&quot;20]. The risk of myocardial infarction after mild"/>
 <result pre="failure due to septic shock [13, 18â€&quot;20]. The risk of" exact="myocardial infarction" post="after mild respiratory infection returns to baseline within approximately"/>
 <result pre="shock [13, 18â€&quot;20]. The risk of myocardial infarction after mild" exact="respiratory" post="infection returns to baseline within approximately 5Â weeks, but"/>
 <result pre="[13, 18â€&quot;20]. The risk of myocardial infarction after mild respiratory" exact="infection" post="returns to baseline within approximately 5Â weeks, but in"/>
 <result pre="baseline within approximately 5Â weeks, but in the case of" exact="pneumonia" post="complicated by sepsis the risk persists up to 10Â"/>
 <result pre="sepsis the risk persists up to 10Â years after the" exact="infection" post="[16] [21]. Infectious agents (including influenza virus) have been"/>
 <result pre="persists up to 10Â years after the infection [16] [21]." exact="Infectious" post="agents (including influenza virus) have been implicated in the"/>
 <result pre="(including influenza virus) have been implicated in the etiology of" exact="atherosclerosis" post="[22]. There have been described several mechanisms by which"/>
 <result pre="described several mechanisms by which influenza increases the risk of" exact="cardiovascular" post="events; they may be related to pro-inflammatory mediators, sympathetic"/>
 <result pre="stimulation, and the activation of the coagulation cascade [19]. Myocardial" exact="Infarction" post="According to the fourth universal definition of myocardial infarction,"/>
 <result pre="[19]. Myocardial Infarction According to the fourth universal definition of" exact="myocardial infarction," post="there are 5 types of myocardial infarction based on"/>
 <result pre="universal definition of myocardial infarction, there are 5 types of" exact="myocardial infarction" post="based on clinical, electrocardiographic, and laboratory evaluation [23]. Influenza"/>
 <result pre="infarction based on clinical, electrocardiographic, and laboratory evaluation [23]. Influenza" exact="infection" post="can trigger type 1 and type 2 myocardial infarctions"/>
 <result pre="clinical, electrocardiographic, and laboratory evaluation [23]. Influenza infection can trigger" exact="type 1" post="and type 2 myocardial infarctions [16]. Type 1 myocardial"/>
 <result pre="laboratory evaluation [23]. Influenza infection can trigger type 1 and" exact="type 2" post="myocardial infarctions [16]. Type 1 myocardial infarction is defined"/>
 <result pre="can trigger type 1 and type 2 myocardial infarctions [16]." exact="Type 1" post="myocardial infarction is defined as myocardial ischemia caused by"/>
 <result pre="type 1 and type 2 myocardial infarctions [16]. Type 1" exact="myocardial infarction" post="is defined as myocardial ischemia caused by atherothrombotic coronary"/>
 <result pre="myocardial infarctions [16]. Type 1 myocardial infarction is defined as" exact="myocardial ischemia" post="caused by atherothrombotic coronary artery disease, and it is"/>
 <result pre="infarctions [16]. Type 1 myocardial infarction is defined as myocardial" exact="ischemia" post="caused by atherothrombotic coronary artery disease, and it is"/>
 <result pre="myocardial infarction is defined as myocardial ischemia caused by atherothrombotic" exact="coronary artery disease," post="and it is usually precipitated by atherosclerotic plaque disruption"/>
 <result pre="infarction is defined as myocardial ischemia caused by atherothrombotic coronary" exact="artery disease," post="and it is usually precipitated by atherosclerotic plaque disruption"/>
 <result pre="pro-inflammatory cytokines, such as interleukins 1, 6, and 8, and" exact="tumor" post="necrosis factor Î± are generated as a response of"/>
 <result pre="cytokines can activate inflammatory cells in atherosclerotic plaques [16] [24]." exact="Acute" post="influenza infection is associated to a procoagulant state that"/>
 <result pre="activate inflammatory cells in atherosclerotic plaques [16] [24]. Acute influenza" exact="infection" post="is associated to a procoagulant state that increases the"/>
 <result pre="associated to a procoagulant state that increases the risk of" exact="coronary thrombosis" post="at sites of plaque disruption [16] [25, 26]. Infection"/>
 <result pre="to a procoagulant state that increases the risk of coronary" exact="thrombosis" post="at sites of plaque disruption [16] [25, 26]. Infection"/>
 <result pre="coronary thrombosis at sites of plaque disruption [16] [25, 26]." exact="Infection" post="with influenza virus is associated with expression of genes"/>
 <result pre="exposure increases platelet gene expression signature, which is associated with" exact="myocardial infarction" post="[25]. Type 2 myocardial infarction might be considered with"/>
 <result pre="gene expression signature, which is associated with myocardial infarction [25]." exact="Type 2" post="myocardial infarction might be considered with a rise and/or"/>
 <result pre="signature, which is associated with myocardial infarction [25]. Type 2" exact="myocardial infarction" post="might be considered with a rise and/or fall of"/>
 <result pre="an imbalance between myocardial oxygen supply and demand unrelated to" exact="coronary thrombosis." post="[23]. Influenza infection produces a systemic inflammatory response with"/>
 <result pre="oxygen supply and demand unrelated to coronary thrombosis. [23]. Influenza" exact="infection" post="produces a systemic inflammatory response with a resulting increase"/>
 <result pre="demand unrelated to coronary thrombosis. [23]. Influenza infection produces a" exact="systemic" post="inflammatory response with a resulting increase in heart rate"/>
 <result pre="produces a systemic inflammatory response with a resulting increase in" exact="heart" post="rate and shortens the filling time during diastole compromising"/>
 <result pre="diastole compromising in that way, the coronary blood supply. If" exact="septic shock" post="occurs, it may have a substantial adverse effect on"/>
 <result pre="substantial adverse effect on coronary perfusion. In older patients with" exact="chronic" post="coronary plaques, systemic inflammation causes cardiac metabolic mismatch increasing"/>
 <result pre="on coronary perfusion. In older patients with chronic coronary plaques," exact="systemic" post="inflammation causes cardiac metabolic mismatch increasing the risk of"/>
 <result pre="systemic inflammation causes cardiac metabolic mismatch increasing the risk of" exact="myocardial infarction" post="[16, 18]. Heart Failure Influenza infection is also associated"/>
 <result pre="metabolic mismatch increasing the risk of myocardial infarction [16, 18]." exact="Heart Failure" post="Influenza infection is also associated with increased mortality in"/>
 <result pre="mismatch increasing the risk of myocardial infarction [16, 18]. Heart" exact="Failure" post="Influenza infection is also associated with increased mortality in"/>
 <result pre="the risk of myocardial infarction [16, 18]. Heart Failure Influenza" exact="infection" post="is also associated with increased mortality in patients with"/>
 <result pre="infection is also associated with increased mortality in patients with" exact="heart" post="failure [27] and is vulnerable to influenza-associated complications [28]"/>
 <result pre="to influenza-associated complications [28] [29]. This type of patients has" exact="limited" post="cardiac and respiratory reserves and may not tolerate the"/>
 <result pre="[28] [29]. This type of patients has limited cardiac and" exact="respiratory" post="reserves and may not tolerate the metabolic demand and"/>
 <result pre="may not tolerate the metabolic demand and hypoxemia, exacerbating underlying" exact="cardiac disease" post="probably due to an increased sympathetic nervous system activity,"/>
 <result pre="not tolerate the metabolic demand and hypoxemia, exacerbating underlying cardiac" exact="disease" post="probably due to an increased sympathetic nervous system activity,"/>
 <result pre="lead to volume overload [28]. In a healthy heart, severe" exact="acute" post="influenza infection produces pro-inflammatory cytokine level elevations that can"/>
 <result pre="volume overload [28]. In a healthy heart, severe acute influenza" exact="infection" post="produces pro-inflammatory cytokine level elevations that can cause acute"/>
 <result pre="influenza infection produces pro-inflammatory cytokine level elevations that can cause" exact="acute" post="myocarditis [28] [18], characterized by a broad spectrum of"/>
 <result pre="infection produces pro-inflammatory cytokine level elevations that can cause acute" exact="myocarditis" post="[28] [18], characterized by a broad spectrum of symptoms"/>
 <result pre="of symptoms that go from asymptomatic courses to signs of" exact="myocardial infarction" post="to devastating illness with cardiogenic shock [30] [31]. Myocarditis"/>
 <result pre="courses to signs of myocardial infarction to devastating illness with" exact="cardiogenic shock" post="[30] [31]. Myocarditis often results from common viral infections"/>
 <result pre="with cardiogenic shock [30] [31]. Myocarditis often results from common" exact="viral" post="infections and post-viral immune-mediated responses [30]. In acute myocarditis,"/>
 <result pre="cardiogenic shock [30] [31]. Myocarditis often results from common viral" exact="infections" post="and post-viral immune-mediated responses [30]. In acute myocarditis, there"/>
 <result pre="from common viral infections and post-viral immune-mediated responses [30]. In" exact="acute" post="myocarditis, there is a high incidence of wall motion"/>
 <result pre="of the patients admitted to a military hospital with influenza" exact="infection" post="had wall motion abnormalities on echocardiogram [18]. This becomes"/>
 <result pre="becomes important, due to the fact that the myocardium inflammatory" exact="disease" post="is regarded as a precursor of dilated cardiomyopathy [30]"/>
 <result pre="the myocardium inflammatory disease is regarded as a precursor of" exact="dilated cardiomyopathy" post="[30] [32]. The electrocardiographic findings in patients with myocarditis"/>
 <result pre="myocardium inflammatory disease is regarded as a precursor of dilated" exact="cardiomyopathy" post="[30] [32]. The electrocardiographic findings in patients with myocarditis"/>
 <result pre="dilated cardiomyopathy [30] [32]. The electrocardiographic findings in patients with" exact="myocarditis" post="range from nonspecific T-wave and ST segment changes to"/>
 <result pre="and ST segment changes to ST segment elevation resembling an" exact="acute" post="myocardial infarction; supraventricular and ventricular arrhythmias can also be"/>
 <result pre="ST segment changes to ST segment elevation resembling an acute" exact="myocardial infarction;" post="supraventricular and ventricular arrhythmias can also be present. Electrocardiographic"/>
 <result pre="the incidence and hemodynamic consequences of right ventricular and left" exact="ventricular dysfunction" post="in patients with H1N1 infection demonstrated that on admission"/>
 <result pre="right ventricular and left ventricular dysfunction in patients with H1N1" exact="infection" post="demonstrated that on admission 72% had abnormal ventricular function"/>
 <result pre="but left ventricular function tended to normalize. However, patients with" exact="ventricular dysfunction" post="needed more aggressive therapy and of rescue ventilatory strategies,"/>
 <result pre="cerebrovascular diseases increase [33]. An increase in incidence of ischemic" exact="stroke" post="within 2Â weeks after influenza infection has been suggested"/>
 <result pre="in incidence of ischemic stroke within 2Â weeks after influenza" exact="infection" post="has been suggested [34, 35]. Protein C pathway and"/>
 <result pre="2Â weeks after influenza infection has been suggested [34, 35]." exact="Protein" post="C pathway and endogenous fibrinolysis are mechanisms associated with"/>
 <result pre="Protein C pathway and endogenous fibrinolysis are mechanisms associated with" exact="cerebrovascular ischemia" post="and influenza infection [19]. Influenza infection develops a prothrombotic"/>
 <result pre="C pathway and endogenous fibrinolysis are mechanisms associated with cerebrovascular" exact="ischemia" post="and influenza infection [19]. Influenza infection develops a prothrombotic"/>
 <result pre="endogenous fibrinolysis are mechanisms associated with cerebrovascular ischemia and influenza" exact="infection" post="[19]. Influenza infection develops a prothrombotic state by increasing"/>
 <result pre="mechanisms associated with cerebrovascular ischemia and influenza infection [19]. Influenza" exact="infection" post="develops a prothrombotic state by increasing tissue factor expression"/>
 <result pre="cerebrovascular ischemia and influenza infection [19]. Influenza infection develops a" exact="prothrombotic state" post="by increasing tissue factor expression and decreases fibrinolytic capacity"/>
 <result pre="an unbalance between coagulation and anticoagulant pathways [36]. As in" exact="myocardial infarction," post="the relationship between systemic inflammation and stroke pathophysiology has"/>
 <result pre="anticoagulant pathways [36]. As in myocardial infarction, the relationship between" exact="systemic" post="inflammation and stroke pathophysiology has shown that stroke often"/>
 <result pre="As in myocardial infarction, the relationship between systemic inflammation and" exact="stroke" post="pathophysiology has shown that stroke often occurs in a"/>
 <result pre="relationship between systemic inflammation and stroke pathophysiology has shown that" exact="stroke" post="often occurs in a pre-existing state of inflammation due"/>
 <result pre="a pre-existing state of inflammation due to atherosclerosis, obesity, or" exact="infection" post="[37]. Possible Cardioprotective Effects of Influenza Vaccination The Sixth"/>
 <result pre="infection [37]. Possible Cardioprotective Effects of Influenza Vaccination The Sixth" exact="Joint" post="Task Force of the European Society of Cardiology and"/>
 <result pre="the European Society of Cardiology and Other Societies on Cardiovascular" exact="Disease" post="Prevention in Clinical Practice recommend that annual influenza vaccination"/>
 <result pre="annual influenza vaccination can be considered in patients with established" exact="cardiovascular disease" post="(class IIb, level C) [38], based on the fact"/>
 <result pre="influenza vaccination can be considered in patients with established cardiovascular" exact="disease" post="(class IIb, level C) [38], based on the fact"/>
 <result pre="[38], based on the fact that the risk of a" exact="cardiovascular" post="event (myocardial infarction or stroke) is more than four"/>
 <result pre="or stroke) is more than four times higher after a" exact="respiratory" post="tract infection, with the highest risk in the first"/>
 <result pre="with the highest risk in the first 3Â days after" exact="infection" post="[39]. There have been developed several studies that demonstrate"/>
 <result pre="studies that demonstrate that influenza vaccination reduces mortality, hospitalization, and" exact="acute" post="coronary syndromes in patients with coronary heart disease and/or"/>
 <result pre="reduces mortality, hospitalization, and acute coronary syndromes in patients with" exact="coronary heart disease" post="and/or heart failure [13]. The mechanisms by which acute"/>
 <result pre="mortality, hospitalization, and acute coronary syndromes in patients with coronary" exact="heart" post="disease and/or heart failure [13]. The mechanisms by which"/>
 <result pre="hospitalization, and acute coronary syndromes in patients with coronary heart" exact="disease" post="and/or heart failure [13]. The mechanisms by which acute"/>
 <result pre="acute coronary syndromes in patients with coronary heart disease and/or" exact="heart" post="failure [13]. The mechanisms by which acute inflammation affect"/>
 <result pre="heart disease and/or heart failure [13]. The mechanisms by which" exact="acute" post="inflammation affect the risk of vascular events include the"/>
 <result pre="The mechanisms by which acute inflammation affect the risk of" exact="vascular" post="events include the following: endothelial dysfunction, procoagulant state, and"/>
 <result pre="atherosclerotic plaques [39, 40]. It is also known that persistent" exact="systemic" post="inflammatory activity is a risk of factor for cardiovascular"/>
 <result pre="persistent systemic inflammatory activity is a risk of factor for" exact="cardiovascular disease," post="and higher interleukin-6 blood levels increase cardiovascular mortality at"/>
 <result pre="factor for cardiovascular disease, and higher interleukin-6 blood levels increase" exact="cardiovascular" post="mortality at one year after pneumonia infection [41]. This"/>
 <result pre="interleukin-6 blood levels increase cardiovascular mortality at one year after" exact="pneumonia" post="infection [41]. This systemic inflammatory response can be reduced"/>
 <result pre="blood levels increase cardiovascular mortality at one year after pneumonia" exact="infection" post="[41]. This systemic inflammatory response can be reduced by"/>
 <result pre="cardiovascular mortality at one year after pneumonia infection [41]. This" exact="systemic" post="inflammatory response can be reduced by vaccination [13]. When"/>
 <result pre="and benefit of interventions to prevent pneumonia, the association of" exact="pneumonia" post="with cardiovascular disease risk should also be considered [40]."/>
 <result pre="of interventions to prevent pneumonia, the association of pneumonia with" exact="cardiovascular disease" post="risk should also be considered [40]. Patients with chronic"/>
 <result pre="interventions to prevent pneumonia, the association of pneumonia with cardiovascular" exact="disease" post="risk should also be considered [40]. Patients with chronic"/>
 <result pre="cardiovascular disease risk should also be considered [40]. Patients with" exact="chronic" post="heart failure are vulnerable to influenza-related complications (including secondary"/>
 <result pre="disease risk should also be considered [40]. Patients with chronic" exact="heart" post="failure are vulnerable to influenza-related complications (including secondary infections,"/>
 <result pre="with chronic heart failure are vulnerable to influenza-related complications (including" exact="secondary" post="infections, such as pneumonia and acute heart failure exacerbations)."/>
 <result pre="are vulnerable to influenza-related complications (including secondary infections, such as" exact="pneumonia" post="and acute heart failure exacerbations). Recently, the PARADIGM-HF Trial"/>
 <result pre="to influenza-related complications (including secondary infections, such as pneumonia and" exact="acute" post="heart failure exacerbations). Recently, the PARADIGM-HF Trial assessed associations"/>
 <result pre="influenza-related complications (including secondary infections, such as pneumonia and acute" exact="heart" post="failure exacerbations). Recently, the PARADIGM-HF Trial assessed associations between"/>
 <result pre="the PARADIGM-HF Trial assessed associations between receiving influenza vaccine and" exact="cardiovascular" post="death or heart failure hospitalizations, all-cause hospitalizations, and cardiopulmonary"/>
 <result pre="assessed associations between receiving influenza vaccine and cardiovascular death or" exact="heart" post="failure hospitalizations, all-cause hospitalizations, and cardiopulmonary or influenza-related hospitalizations,"/>
 <result pre="described two possible mechanisms by which influenza vaccination may reduce" exact="cardiovascular" post="events: unspecific and specific effects [13]. The unspecific mechanism"/>
 <result pre="The unspecific mechanism is based on the fact that influenza" exact="infection" post="causes a systemic inflammatory response, endothelial dysfunction, and a"/>
 <result pre="is based on the fact that influenza infection causes a" exact="systemic" post="inflammatory response, endothelial dysfunction, and a procoagulant state. These"/>
 <result pre="state. These factors have negative effects on patients with previous" exact="cardiovascular" post="diseases, such as ischemic heart disease and heart failure,"/>
 <result pre="negative effects on patients with previous cardiovascular diseases, such as" exact="ischemic heart disease" post="and heart failure, causing acute heart failure, pulmonary edema,"/>
 <result pre="effects on patients with previous cardiovascular diseases, such as ischemic" exact="heart" post="disease and heart failure, causing acute heart failure, pulmonary"/>
 <result pre="on patients with previous cardiovascular diseases, such as ischemic heart" exact="disease" post="and heart failure, causing acute heart failure, pulmonary edema,"/>
 <result pre="patients with previous cardiovascular diseases, such as ischemic heart disease" exact="and heart" post="failure, causing acute heart failure, pulmonary edema, or destabilization"/>
 <result pre="with previous cardiovascular diseases, such as ischemic heart disease and" exact="heart" post="failure, causing acute heart failure, pulmonary edema, or destabilization"/>
 <result pre="diseases, such as ischemic heart disease and heart failure, causing" exact="acute" post="heart failure, pulmonary edema, or destabilization of chronic ischemic"/>
 <result pre="such as ischemic heart disease and heart failure, causing acute" exact="heart" post="failure, pulmonary edema, or destabilization of chronic ischemic heart"/>
 <result pre="ischemic heart disease and heart failure, causing acute heart failure," exact="pulmonary" post="edema, or destabilization of chronic ischemic heart disease, leading"/>
 <result pre="failure, causing acute heart failure, pulmonary edema, or destabilization of" exact="chronic" post="ischemic heart disease, leading to myocardial infarction or sudden"/>
 <result pre="causing acute heart failure, pulmonary edema, or destabilization of chronic" exact="ischemic heart disease," post="leading to myocardial infarction or sudden cardiac death [13]"/>
 <result pre="acute heart failure, pulmonary edema, or destabilization of chronic ischemic" exact="heart" post="disease, leading to myocardial infarction or sudden cardiac death"/>
 <result pre="edema, or destabilization of chronic ischemic heart disease, leading to" exact="myocardial infarction" post="or sudden cardiac death [13] [15]. Influenza vaccination reduces"/>
 <result pre="cardiac death [13] [15]. Influenza vaccination reduces the risk of" exact="infection" post="and inflammation by decreasing the secretion of pro-inflammatory mediators,"/>
 <result pre="[22]. It has also been proposed that there is an" exact="autoimmune" post="â€œcross-reactionâ€� between influenza and atherosclerosis [13] [44]. Figure 1"/>
 <result pre="proposed that there is an autoimmune â€œcross-reactionâ€� between influenza and" exact="atherosclerosis" post="[13] [44]. Figure 1 summarizes the possible cardioprotective mechanism"/>
 <result pre="Conclusion It is well studied that obese patients can develop" exact="cardiovascular" post="diseases; however, it is less known that the low-inflammatory"/>
 <result pre="cardiovascular diseases; however, it is less known that the low-inflammatory" exact="chronic" post="state might affect host defense and immune cell dysfunction"/>
 <result pre="such patients, such as an increased risk, length of hospitalization," exact="disease" post="severity, morbidity, and mortality. Cardiovascular diseases, such as ischemic"/>
 <result pre="hospitalization, disease severity, morbidity, and mortality. Cardiovascular diseases, such as" exact="ischemic heart disease" post="and heart failure combined with influenza A infection, can"/>
 <result pre="disease severity, morbidity, and mortality. Cardiovascular diseases, such as ischemic" exact="heart" post="disease and heart failure combined with influenza A infection,"/>
 <result pre="severity, morbidity, and mortality. Cardiovascular diseases, such as ischemic heart" exact="disease" post="and heart failure combined with influenza A infection, can"/>
 <result pre="morbidity, and mortality. Cardiovascular diseases, such as ischemic heart disease" exact="and heart" post="failure combined with influenza A infection, can trigger acute"/>
 <result pre="and mortality. Cardiovascular diseases, such as ischemic heart disease and" exact="heart" post="failure combined with influenza A infection, can trigger acute"/>
 <result pre="and heart failure combined with influenza A infection, can trigger" exact="acute" post="heart failure exacerbations that increase the overall mortality in"/>
 <result pre="heart failure combined with influenza A infection, can trigger acute" exact="heart" post="failure exacerbations that increase the overall mortality in a"/>
 <result pre="mortality in a hospitalized setting. Cardiovascular complications associated with influenza" exact="infection" post="include myocarditis, pericardial effusion, myopericarditis, right and left ventricle"/>
 <result pre="hospitalized setting. Cardiovascular complications associated with influenza infection include myocarditis," exact="pericardial effusion," post="myopericarditis, right and left ventricle dysfunction, myocardial infarction, heart"/>
 <result pre="include myocarditis, pericardial effusion, myopericarditis, right and left ventricle dysfunction," exact="myocardial infarction," post="heart failure, stroke, and circulatory failure due to septic"/>
 <result pre="pericardial effusion, myopericarditis, right and left ventricle dysfunction, myocardial infarction," exact="heart" post="failure, stroke, and circulatory failure due to septic shock."/>
 <result pre="myocardial infarction, heart failure, stroke, and circulatory failure due to" exact="septic shock." post="There have been described several mechanisms by which influenza"/>
 <result pre="described several mechanisms by which influenza increases the risk of" exact="cardiovascular" post="events; they might be related to pro-inflammatory mediators, sympathetic"/>
 <result pre="a significant reduction in all-cause mortality risk in patients with" exact="heart" post="failure, this cardioprotective mechanism may not function as intended"/>
 <result pre="in an effort to prevent these complications and in the" exact="absence of" post="special consideration treatments for this population, we strongly suggest"/>
 <result pre="patient. This article is part of the Topical Collection on" exact="Metabolism" post="in Tropical Medicine Publisherâ€™s Note Springer Nature remains neutral"/>
 <result pre="â€¢ Of importance 1.â€¢ Honce R, Schultz-Cherry S. Impact of" exact="obesity" post="on influenza A virus pathogenesis, immune response, and evolution."/>
 <result pre="more cellular approach. 2.Milner JJ, Beck MA. The impact of" exact="obesity" post="on the immune response to infection. In: Proceedings of"/>
 <result pre="the Nutrition Societ. Proc Nutr Soc; 2012;71(2):298â€&quot;306. 10.1017/S0029665112000158 3.Obesity and" exact="overweight" post="[Internet]. [cited 2019 Oct 21]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed"/>
 <result pre="Lephart P, et al. Epidemiology of severe influenza outcomes among" exact="adult" post="patients with obesity in Detroit, Michigan, 2011. Influenza Other"/>
 <result pre="al. Epidemiology of severe influenza outcomes among adult patients with" exact="obesity" post="in Detroit, Michigan, 2011. Influenza Other Respi Viruses [Internet]."/>
 <result pre="AnunciaÃ§Ã£o PC, da Silva BP, HMP Sâ€™A. Association between vitamin" exact="deficiency" post="and metabolic disorders related to obesity. Crit Rev Food"/>
 <result pre="Sanchez N, Ng S, Gresh L, Ojeda S, et al." exact="Obesity" post="increases the duration of influenza A virus shedding in"/>
 <result pre="Hertz T, Johnson C, Mehle A, Krammer F, Schultz-Cherry S." exact="Obesity" post="outweighs protection conferred by adjuvanted influenza vaccination. MBio [Internet]."/>
 <result pre="Rebeles J, Karlsson EA, Schultz-Cherry S, Noah TL, et al." exact="Increased" post="risk of influenza among vaccinated adults who are obese."/>
 <result pre="Cardioprotective effect of influenza and pneumococcal vaccination in patients with" exact="cardiovascular" post="diseases [Internet]. Vaccine. 2018;36:202â€&quot;6 [cited 2019 Oct 15]. Available"/>
 <result pre="Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing" exact="cardiovascular disease." post="Cochrane Database Syst Rev [Internet]. 2015;(5):CD005050 [cited 2019 Oct"/>
 <result pre="F, Phrommintikul A, et al. Association between influenza vaccination and" exact="cardiovascular" post="outcomes in high-risk patients. JAMA [Internet]. 2013;310(16):1711 [cited 2019"/>
 <result pre="Oct 15]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/24150467. Accessed Oct 15 2019. 16.MusherDMAbersMSCorrales-MedinaVFAcute" exact="infection" post="and myocardial infarctionN Engl J Med2019380217117610.1056/NEJMra180813730625066 17.Kwong JC, Schwartz"/>
 <result pre="Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, et al." exact="Acute" post="myocardial infarction after laboratory-confirmed influenza infection. N Engl J"/>
 <result pre="MA, Chung H, Crowcroft NS, Karnauchow T, et al. Acute" exact="myocardial infarction" post="after laboratory-confirmed influenza infection. N Engl J Med. 2018;378(4):345â€&quot;53."/>
 <result pre="H1N1 influenza infectionJ Crit Care201328432132710.1016/j.jcrc.2013.01.01023566732 19.FountoulakiKTsiodrasSPolyzogopoulouEOlympiosCParissisJBeneficial effects of vaccination on" exact="cardiovascular" post="events: myocardial infarction, stroke, heart failureCardiol.201814129810610.1159/000493572 20.Mamas MA, Fraser"/>
 <result pre="infectionJ Crit Care201328432132710.1016/j.jcrc.2013.01.01023566732 19.FountoulakiKTsiodrasSPolyzogopoulouEOlympiosCParissisJBeneficial effects of vaccination on cardiovascular events:" exact="myocardial infarction," post="stroke, heart failureCardiol.201814129810610.1159/000493572 20.Mamas MA, Fraser D, Neyses L."/>
 <result pre="19.FountoulakiKTsiodrasSPolyzogopoulouEOlympiosCParissisJBeneficial effects of vaccination on cardiovascular events: myocardial infarction, stroke," exact="heart" post="failureCardiol.201814129810610.1159/000493572 20.Mamas MA, Fraser D, Neyses L. Cardiovascular manifestations"/>
 <result pre="MA, Fraser D, Neyses L. Cardiovascular manifestations associated with influenza" exact="virus infection." post="Int J Cardiol. 2008;130:304â€&quot;9. 21.BerghCFallKUdumyanRSjÃ¶qvistHFrÃ¶bertOMontgomerySSevere infections and subsequent delayed"/>
 <result pre="associated with influenza virus infection. Int J Cardiol. 2008;130:304â€&quot;9. 21.BerghCFallKUdumyanRSjÃ¶qvistHFrÃ¶bertOMontgomerySSevere" exact="infections" post="and subsequent delayed cardiovascular diseaseEur J Prev Cardiol201724181958196610.1177/204748731772400928764553 22.Madjid"/>
 <result pre="infection. Int J Cardiol. 2008;130:304â€&quot;9. 21.BerghCFallKUdumyanRSjÃ¶qvistHFrÃ¶bertOMontgomerySSevere infections and subsequent delayed" exact="cardiovascular" post="diseaseEur J Prev Cardiol201724181958196610.1177/204748731772400928764553 22.Madjid M, Naghavi M, Litovsky"/>
 <result pre="22.Madjid M, Naghavi M, Litovsky S, Casscells SW. Influenza and" exact="cardiovascular" post="disease: a new opportunity for prevention and the need"/>
 <result pre="Bax JJ, Morrow DA, et al. Fourth universal definition of" exact="myocardial infarction" post="(2018). J Am Coll Cardiol. 2018;72(18):2231â€&quot;64. 24.Mauriello A, Sangiorgi"/>
 <result pre="Fratoni S, Palmieri G, Bonanno E, Anemona L, et al." exact="Diffuse" post="and active inflammation occurs in both vulnerable and stable"/>
 <result pre="al. Diffuse and active inflammation occurs in both vulnerable and" exact="stable" post="plaques of the entire coronary tree: a histopathologic study"/>
 <result pre="entire coronary tree: a histopathologic study of patients dying of" exact="acute" post="myocardial infarction. J Am Coll Cardiol. 2005;45(10):1585â€&quot;93. 25.Rose JJ,"/>
 <result pre="coronary tree: a histopathologic study of patients dying of acute" exact="myocardial infarction." post="J Am Coll Cardiol. 2005;45(10):1585â€&quot;93. 25.Rose JJ, Voora D,"/>
 <result pre="Zaas AK, Woods CW, et al. Gene expression profiles link" exact="respiratory" post="viral infection, platelet response to aspirin, and acute myocardial"/>
 <result pre="AK, Woods CW, et al. Gene expression profiles link respiratory" exact="viral infection," post="platelet response to aspirin, and acute myocardial infarction. Schulz"/>
 <result pre="profiles link respiratory viral infection, platelet response to aspirin, and" exact="acute" post="myocardial infarction. Schulz C, editor. PLoS One [Internet]. 2015"/>
 <result pre="link respiratory viral infection, platelet response to aspirin, and acute" exact="myocardial infarction." post="Schulz C, editor. PLoS One [Internet]. 2015 10(7):e0132259. [cited"/>
 <result pre="2019. 26.Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis," exact="thrombosis" post="and organ dysfunction. Thromb Res. 2012;129:290â€&quot;5. 27.Panhwar MS, Kalra"/>
 <result pre="D, Khera S, Bhatt D, et al. Relation of concomitant" exact="heart" post="failure to outcomes in patients hospitalized with influenza. Am"/>
 <result pre="et al. Association of influenza-like illness activity with hospitalizations for" exact="heart" post="failure: the atherosclerosis risk in communities study. JAMA Cardiol."/>
 <result pre="of influenza-like illness activity with hospitalizations for heart failure: the" exact="atherosclerosis" post="risk in communities study. JAMA Cardiol. 2019;4(4):363â€&quot;9. 29.VardenyOSweitzerNKDetryMAMoranJMJohnsonMRHayneyMSDecreased immune"/>
 <result pre="2019;4(4):363â€&quot;9. 29.VardenyOSweitzerNKDetryMAMoranJMJohnsonMRHayneyMSDecreased immune responses to influenza vaccination in patients with" exact="heart" post="failureJ Card Fail200915436837310.1016/j.cardfail.2008.11.00919398087 30.Kindermann I, Barth C, Mahfoud F,"/>
 <result pre="of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur" exact="Heart" post="J. 2013;34(33):2636â€&quot;48. 32.TschÃ¶peCCooperLTTorre-AmioneGVan LinthoutSManagement of myocarditis-related cardiomyopathy in adultsCirc"/>
 <result pre="Pericardial Diseases. Eur Heart J. 2013;34(33):2636â€&quot;48. 32.TschÃ¶peCCooperLTTorre-AmioneGVan LinthoutSManagement of myocarditis-related" exact="cardiomyopathy" post="in adultsCirc Res2019124111568158310.1161/CIRCRESAHA.118.31357831120823 33.NicholKLNordinJMulloolyJLaskRFillbrandtKIwaneMInfluenza vaccination and reduction in hospitalizations"/>
 <result pre="in adultsCirc Res2019124111568158310.1161/CIRCRESAHA.118.31357831120823 33.NicholKLNordinJMulloolyJLaskRFillbrandtKIwaneMInfluenza vaccination and reduction in hospitalizations for" exact="cardiac disease" post="and stroke among the elderlyN Engl J Med2003348141322133210.1056/NEJMoa02502812672859 34.Toschke"/>
 <result pre="adultsCirc Res2019124111568158310.1161/CIRCRESAHA.118.31357831120823 33.NicholKLNordinJMulloolyJLaskRFillbrandtKIwaneMInfluenza vaccination and reduction in hospitalizations for cardiac" exact="disease" post="and stroke among the elderlyN Engl J Med2003348141322133210.1056/NEJMoa02502812672859 34.Toschke"/>
 <result pre="33.NicholKLNordinJMulloolyJLaskRFillbrandtKIwaneMInfluenza vaccination and reduction in hospitalizations for cardiac disease and" exact="stroke" post="among the elderlyN Engl J Med2003348141322133210.1056/NEJMoa02502812672859 34.Toschke AM, Heuschmann"/>
 <result pre="Heuschmann PU, Wood O, Wolfe CDA. Temporal relationship between influenza" exact="infections" post="and subsequent first-ever stroke incidence. Age Ageing. 2009;38:100â€&quot;3. 35.BoehmeAKLunaJKulickERKamelHElkindMSVInfluenza-like"/>
 <result pre="Wolfe CDA. Temporal relationship between influenza infections and subsequent first-ever" exact="stroke" post="incidence. Age Ageing. 2009;38:100â€&quot;3. 35.BoehmeAKLunaJKulickERKamelHElkindMSVInfluenza-like illness as a trigger"/>
 <result pre="Transl Neurol20185445646310.1002/acn3.54529687022 36.Urbanek C, Palm F, Grau A. Influenza and" exact="stroke" post="risk: a key target not to be missed? Infect"/>
 <result pre="Jan 12]; Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&amp;amp;issn=1871-5265&amp;amp;volume=10&amp;amp;issue=2&amp;amp;spage=122. Accessed Jan 12 2019. 37.MuhammadSHaasbachEKotchourkoMStrigliAKrenzARidderDAVogelABMartiHHal-AbedYPlanzOSchwaningerMInfluenza" exact="virus infection" post="aggravates stroke outcomeStroke201142378379110.1161/STROKEAHA.110.59678321293018 38.PiepoliMFHoesAWAgewallSAlbusCBrotonsCCatapanoALet al.G Ital Cardiol (Rome)201718754761228714997 39.SmeethLThomasSLHallAJHubbardRFarringtonPVallancePRisk"/>
 <result pre="12]; Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&amp;amp;issn=1871-5265&amp;amp;volume=10&amp;amp;issue=2&amp;amp;spage=122. Accessed Jan 12 2019. 37.MuhammadSHaasbachEKotchourkoMStrigliAKrenzARidderDAVogelABMartiHHal-AbedYPlanzOSchwaningerMInfluenza virus" exact="infection" post="aggravates stroke outcomeStroke201142378379110.1161/STROKEAHA.110.59678321293018 38.PiepoliMFHoesAWAgewallSAlbusCBrotonsCCatapanoALet al.G Ital Cardiol (Rome)201718754761228714997 39.SmeethLThomasSLHallAJHubbardRFarringtonPVallancePRisk"/>
 <result pre="from: http://www.eurekaselect.com/openurl/content.php?genre=article&amp;amp;issn=1871-5265&amp;amp;volume=10&amp;amp;issue=2&amp;amp;spage=122. Accessed Jan 12 2019. 37.MuhammadSHaasbachEKotchourkoMStrigliAKrenzARidderDAVogelABMartiHHal-AbedYPlanzOSchwaningerMInfluenza virus infection aggravates" exact="stroke" post="outcomeStroke201142378379110.1161/STROKEAHA.110.59678321293018 38.PiepoliMFHoesAWAgewallSAlbusCBrotonsCCatapanoALet al.G Ital Cardiol (Rome)201718754761228714997 39.SmeethLThomasSLHallAJHubbardRFarringtonPVallancePRisk of myocardial"/>
 <result pre="aggravates stroke outcomeStroke201142378379110.1161/STROKEAHA.110.59678321293018 38.PiepoliMFHoesAWAgewallSAlbusCBrotonsCCatapanoALet al.G Ital Cardiol (Rome)201718754761228714997 39.SmeethLThomasSLHallAJHubbardRFarringtonPVallancePRisk of" exact="myocardial infarction" post="and stroke after acute infection or vaccinationN Engl J"/>
 <result pre="38.PiepoliMFHoesAWAgewallSAlbusCBrotonsCCatapanoALet al.G Ital Cardiol (Rome)201718754761228714997 39.SmeethLThomasSLHallAJHubbardRFarringtonPVallancePRisk of myocardial infarction and" exact="stroke" post="after acute infection or vaccinationN Engl J Med2004351252611261810.1056/NEJMoa04174715602021 40.Corrales-MedinaVFAlvarezKNWeissfeldLAAngusDCChirinosJAChangCCHNewmanALoehrLFolsomARElkindMSLylesMFKronmalRAYendeSAssociation"/>
 <result pre="Ital Cardiol (Rome)201718754761228714997 39.SmeethLThomasSLHallAJHubbardRFarringtonPVallancePRisk of myocardial infarction and stroke after" exact="acute" post="infection or vaccinationN Engl J Med2004351252611261810.1056/NEJMoa04174715602021 40.Corrales-MedinaVFAlvarezKNWeissfeldLAAngusDCChirinosJAChangCCHNewmanALoehrLFolsomARElkindMSLylesMFKronmalRAYendeSAssociation between hospitalization"/>
 <result pre="Cardiol (Rome)201718754761228714997 39.SmeethLThomasSLHallAJHubbardRFarringtonPVallancePRisk of myocardial infarction and stroke after acute" exact="infection" post="or vaccinationN Engl J Med2004351252611261810.1056/NEJMoa04174715602021 40.Corrales-MedinaVFAlvarezKNWeissfeldLAAngusDCChirinosJAChangCCHNewmanALoehrLFolsomARElkindMSLylesMFKronmalRAYendeSAssociation between hospitalization for"/>
 <result pre="infection or vaccinationN Engl J Med2004351252611261810.1056/NEJMoa04174715602021 40.Corrales-MedinaVFAlvarezKNWeissfeldLAAngusDCChirinosJAChangCCHNewmanALoehrLFolsomARElkindMSLylesMFKronmalRAYendeSAssociation between hospitalization for" exact="pneumonia" post="and subsequent risk of cardiovascular diseaseJAMA2015313326427410.1001/jama.2014.1822925602997 41.YendeSDâ€™AngeloGKellumJAWeissfeldLFineJWelchRDet al.Inflammatory markers"/>
 <result pre="Med2004351252611261810.1056/NEJMoa04174715602021 40.Corrales-MedinaVFAlvarezKNWeissfeldLAAngusDCChirinosJAChangCCHNewmanALoehrLFolsomARElkindMSLylesMFKronmalRAYendeSAssociation between hospitalization for pneumonia and subsequent risk of" exact="cardiovascular" post="diseaseJAMA2015313326427410.1001/jama.2014.1822925602997 41.YendeSDâ€™AngeloGKellumJAWeissfeldLFineJWelchRDet al.Inflammatory markers at hospital discharge predict subsequent"/>
 <result pre="41.YendeSDâ€™AngeloGKellumJAWeissfeldLFineJWelchRDet al.Inflammatory markers at hospital discharge predict subsequent mortality after" exact="pneumonia" post="and sepsisAm J Respir Crit Care Med2008177111242124710.1164/rccm.200712-1777OC18369199 42.VardenyOClaggettBUdellJAPackerMZileMRouleauJSwedbergKDesaiASLefkowitzMShiVMcMurrayJSolomonSDcollab: PARADIGM-HF"/>
 <result pre="Crit Care Med2008177111242124710.1164/rccm.200712-1777OC18369199 42.VardenyOClaggettBUdellJAPackerMZileMRouleauJSwedbergKDesaiASLefkowitzMShiVMcMurrayJSolomonSDcollab: PARADIGM-HF InvestigatorsInfluenza vaccination in patients with" exact="chronic" post="heart failure: the PARADIGM-HF trialJACC Hear Fail20164215215810.1016/j.jchf.2015.10.012 43.Naghavi M,"/>
 <result pre="Care Med2008177111242124710.1164/rccm.200712-1777OC18369199 42.VardenyOClaggettBUdellJAPackerMZileMRouleauJSwedbergKDesaiASLefkowitzMShiVMcMurrayJSolomonSDcollab: PARADIGM-HF InvestigatorsInfluenza vaccination in patients with chronic" exact="heart" post="failure: the PARADIGM-HF trialJACC Hear Fail20164215215810.1016/j.jchf.2015.10.012 43.Naghavi M, Libby"/>
 <result pre="strategies: part II. Circulation. 2003;108:1772â€&quot;8. 44.VeljkovicVGlisicSVeljkovicNBojicTDietrichUPerovicVRColombattiAInfluenza vaccine as prevention for" exact="cardiovascular" post="diseases: possible molecular mechanismVaccine.201432486569657510.1016/j.vaccine.2014.07.00725045818"/>
</results>
